These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12577304)

  • 21. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
    J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
    Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
    J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway.
    Villa I; Mrak E; Rubinacci A; Ravasi F; Guidobono F
    Am J Physiol Cell Physiol; 2006 Sep; 291(3):C529-37. PubMed ID: 16611736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New paradigms in the regulation of bone metabolism].
    Rosa-Rañal M; de la Cruz DA; Lorena-Rubio Y; Larrea F
    Rev Invest Clin; 2001; 53(4):362-9. PubMed ID: 11599485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
    Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
    J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adhesion molecules in the context with bone remodeling and osteoporosis].
    Tanaka Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
    [No Abstract]   [Full Text] [Related]  

  • 29. Defective bone remodelling in osteoprotegerin-deficient mice.
    Amizuka N; Shimomura J; Li M; Seki Y; Oda K; Henderson JE; Mizuno A; Ozawa H; Maeda T
    J Electron Microsc (Tokyo); 2003; 52(6):503-13. PubMed ID: 14756238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
    Varga F; Spitzer S; Klaushofer K
    Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
    Redlich K; Görtz B; Hayer S; Zwerina J; Doerr N; Kostenuik P; Bergmeister H; Kollias G; Steiner G; Smolen JS; Schett G
    Am J Pathol; 2004 Feb; 164(2):543-55. PubMed ID: 14742260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells.
    Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Yamada N; Sugihara A; Okamura H; Hayashi S; Terada N
    Biochem Biophys Res Commun; 2001 Feb; 281(2):361-6. PubMed ID: 11181055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TSH is a negative regulator of skeletal remodeling.
    Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
    Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
    Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
    J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion.
    Hinoi E; Gao N; Jung DY; Yadav V; Yoshizawa T; Kajimura D; Myers MG; Chua SC; Wang Q; Kim JK; Kaestner KH; Karsenty G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E20-30. PubMed ID: 19751411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin reduces ovariectomy-induced bone loss in rats.
    Burguera B; Hofbauer LC; Thomas T; Gori F; Evans GL; Khosla S; Riggs BL; Turner RT
    Endocrinology; 2001 Aug; 142(8):3546-53. PubMed ID: 11459801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of leptin in bone growth: central player or peripheral supporter?
    Reseland JE; Gordeladze JO
    FEBS Lett; 2002 Sep; 528(1-3):40-2. PubMed ID: 12297276
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone remodeling and mineral homeostasis].
    Nakamura M; Udagawa N; Nakamura H
    Clin Calcium; 2006 Jan; 16(1):46-53. PubMed ID: 16397350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.